Orthovita, Inc. is an American company that manufactures orthobiologic and biosurgery products for spine and orthopedic treatments.

According to the Complaint filed on June 1, 2011, on May 16, 2011, the Defendant issued a press release announcing that it had entered into a definitive merger agreement for the parent to acquire the Defendant, via a tender offer, in a deal with a total enterprise value of approximately $316 million, including debt assumed and net of cash acquired. Pursuant to the Agreement and Plan of Merger dated May 16, 2011, entered into between the companies, the acquisition company shall commence a cash tender offer to purchase all outstanding shares of the Defendant's common stock at a purchase price of $3.85 per share in cash, to be followed by a merger with the acquisition company and into the Defendant.

On June 14, 2011, the Court dismissed the Plaintiff's motion for expedited discovery as requested and stayed several Defendants' motions to dismiss.

On May 7, 2012, the Court issued an order granting preliminary approval of settlement.

On August 16, 2012, the Court entered an order and Final Judgment.